Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03856879 · ClinicalTrials.gov registry record · NA
High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults
A NA study, sponsored by Seattle Institute for Biomedical and Clinical Research.
- Completed
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT03856879 is a NA study that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 270 participants.
The verdict
NCT03856879, a NA study, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary care providers (PCP) for their HIV+ patients in the ID clinic. Rather than relying on referral-driven specialty care which may be a barrier to access, pulmonologists will proactively support ID providers to manage a population of HIV+ patients with COPD, delivering real-time evidence-based recommendations tailored to the individual HIV+ patient in the form of an E-consult.
Interventions
- BEHAVIORAL Proactive E-consult
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2019-05-21 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03856879
The ClinicalTrials.gov registry entry for NCT03856879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proactive E-consult is the first listed.
NCT03856879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03856879 about?
NCT03856879 is a clinical study titled "High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults". This study examines an intervention to promote effective, evidence-based care and de-implement inappropriate therapies for COPD in HIV-infected (HIV+) patients. The intervention facilitates specialist support of primary care, which includes infectious disease (ID) physicians who serve as the primary...
What is the current status of trial NCT03856879?
This trial is currently completed. It is a NA study. The enrollment target is 270 participants. The study started on 2019-05-21. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT03856879?
The interventions under investigation include: Proactive E-consult (BEHAVIORAL).
Who is sponsoring clinical trial NCT03856879?
This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.